Larissa Thackray
Washington University in St. Louis
H-index: 44
North America-United States
Top articles of Larissa Thackray
Title | Journal | Author(s) | Publication Date |
|---|---|---|---|
Compositions and methods for inhibition of alphavirus infection | 2020/12/31 | ||
A compendium of multi-omics data illuminating host responses to lethal human virus infections | Scientific Data | Amie J Eisfeld Lindsey N Anderson Shufang Fan Kevin B Walters Peter J Halfmann | 2024/4/2 |
Ipsilateral or contralateral boosting of mice with mRNA vaccines confers equivalent immunity and protection against a SARS-CoV-2 Omicron strain | bioRxiv | Baoling Ying Chieh-Yu Liang Pritesh Desai Suzanne Scheaffer Sayda Elbashir | 2024 |
Intestinal helminth infection impairs vaccine-induced T cell responses and protection against SARS-CoV-2 (preprint) | bioRxiv | Pritesh Desai Courtney E Karl Baoling Ying Chieh-Yu Liang Tamara Garcia-Salum | 2024 |
Genetic loci regulate Sarbecovirus pathogenesis: A comparison across mice and humans | Virus Research | Alexandra Schäfer Lisa E Gralinski Sarah R Leist Brea K Hampton Michael A Mooney | 2024/6/1 |
Domain-based mRNA vaccines encoding spike protein N-terminal and receptor binding domains confer protection against SARS-CoV-2 | Science translational medicine | Guillaume BE Stewart-Jones Sayda M Elbashir Kai Wu Diana Lee Isabella Renzi | 2023/9/13 |
Compositions and methods for inhibiting viral recognition sites | 2023/6/15 | ||
Bivalent SARS-CoV-2 mRNA vaccines increase breadth of neutralization and protect against the BA. 5 Omicron variant in mice | Nature medicine | Suzanne M Scheaffer Diana Lee Bradley Whitener Baoling Ying Kai Wu | 2023/1 |
An antiviral role for TRIM14 in Ebola virus infection | The Journal of Infectious Diseases | Makoto Kuroda Peter J Halfmann Larissa B Thackray Michael S Diamond Heinz Feldmann | 2023/11/15 |
SARS-CoV-2 Omicron virus causes attenuated disease in mice and hamsters | Nature | Peter J Halfmann Shun Iida Kiyoko Iwatsuki-Horimoto Tadashi Maemura Maki Kiso | 2022/3/24 |
Host network-based discovery of critical regulators of innate immunity, virus growth, and pathogenesis in influenza virus infection | bioRxiv | Amie J Eisfeld Shufang Fan Hongyu Rao Backiyalakshmi Ammayappan Venkatachalam Danielle Westhoff Smith | 2022/8/30 |
Boosting with Omicron-matched or historical mRNA vaccines increases neutralizing antibody responses and protection against B. 1.1. 529 infection in mice | BioRxiv | Baoling Ying Suzanne M Scheaffer Bradley Whitener Chieh-Yu Liang Oleksandr Dmytrenko | 2022/2/9 |
Kathryn V. Holmes: A Career of Contributions to the Coronavirus Field | Aurelio Bonavia Samuel R Dominguez Gabriela Dveksler Sara Gagneten Megan Howard | 2022/7/20 | |
Mesalamine reduces intestinal ACE2 expression without modifying SARS-CoV-2 infection or disease severity in mice | Inflammatory bowel diseases | David M Alvarado Juhee Son Larissa B Thackray Maria Florencia Gomez Castro Sarada Prasad | 2022/2/1 |
Defining the risk of SARS-CoV-2 variants on immune protection | Marciela M DeGrace Elodie Ghedin Matthew B Frieman Florian Krammer Alba Grifoni | 2022/5/26 | |
mRNA-1273 and Ad26. COV2. S vaccines protect against the B. 1.621 variant of SARS-CoV-2 | Med | Tamarand L Darling Baoling Ying Bradley Whitener Laura A VanBlargan Traci L Bricker | 2022/5/13 |
Computationally restoring the potency of a clinical antibody against SARS-CoV-2 Omicron subvariants | bioRxiv | Thomas A Desautels Kathryn T Arrildt Adam T Zemla Edmond Y Lau Fangqiang Zhu | 2022/10/24 |
Boosting with variant-matched or historical mRNA vaccines protects against Omicron infection in mice | Cell | Baoling Ying Suzanne M Scheaffer Bradley Whitener Chieh-Yu Liang Oleksandr Dmytrenko | 2022/4/28 |
Development of SARS-CoV-2 mRNA vaccines encoding spike N-terminal and receptor binding domains | bioRxiv | Guillaume BE Stewart-Jones Sayda M Elbashir Kai Wu Diana Lee Isabella Renzi | 2022/10/7 |
Helminth–virus interactions: determinants of coinfection outcomes | Pritesh Desai Michael S Diamond Larissa B Thackray | 2021/1/1 |
